AboutNeuron TypesElectrophysiology PropertiesArticlesFAQsData/APIGet Involved

Article: Postnatal day 2 to 11 constitutes a 5-HT-sensitive period impacting adult mPFC function.

Full Text (publisher's website) ; Article Metadata ; Article Data (extracted)
Rebello TJ; Yu Q; Goodfellow NM; Caffrey Cagliostro MK; Teissier A; Morelli E; Demireva EY; Chemiakine A; Rosoklija GB; Dwork AJ; Lambe EK; Gingrich JA; Ansorge MS
J. Neurosci., 2014

Inferred neuron-electrophysiology data values

Neuron Type Neuron Description Ephys Prop Extracted Value Standardized Value Content Source
Neocortex pyramidal cell layer 2-3 Medial prefrontal cortex layer 2-3 prelimbic pyramidal cell cell capacitance (pF) 99.8 ± 7.5 (10) 99.8 (pF) Data Table
Neocortex pyramidal cell layer 2-3 Medial prefrontal cortex layer 2-3 infralimbic pyramidal cell cell capacitance (pF) 86.5 ± 5.0 (13) 86.5 (pF) Data Table
Neocortex pyramidal cell layer 2-3 Medial prefrontal cortex layer 2-3 infralimbic pyramidal cell input resistance (MΩ) 165.0 ± 25.9 (13) 165.0 (MΩ) Data Table
Neocortex pyramidal cell layer 2-3 Medial prefrontal cortex layer 2-3 prelimbic pyramidal cell input resistance (MΩ) 77.9 ± 15.4 (10) 77.9 (MΩ) Data Table
Neocortex pyramidal cell layer 2-3 Medial prefrontal cortex layer 2-3 infralimbic pyramidal cell resting membrane potential (mV) -85.5 ± 2.8 (13) -85.5 (mV) Data Table
Neocortex pyramidal cell layer 2-3 Medial prefrontal cortex layer 2-3 prelimbic pyramidal cell resting membrane potential (mV) -86.6 ± 2.4 (10) -86.6 (mV) Data Table
Neocortex pyramidal cell layer 2-3 Medial prefrontal cortex layer 2-3 infralimbic pyramidal cell rheobase (pA) 134.0 ± 26.0 (13) 134.0 (pA) Data Table
Neocortex pyramidal cell layer 2-3 Medial prefrontal cortex layer 2-3 prelimbic pyramidal cell rheobase (pA) 255.0 ± 31.0 (10) 255.0 (pA) Data Table
Neocortex pyramidal cell layer 2-3 Medial prefrontal cortex layer 2-3 prelimbic pyramidal cell spike amplitude (mV) 88.5 ± 1.1 (10) 88.5 (mV) Data Table
Neocortex pyramidal cell layer 2-3 Medial prefrontal cortex layer 2-3 infralimbic pyramidal cell spike amplitude (mV) 87.3 ± 1.5 (13) 87.3 (mV) Data Table

Report miscurated data

Metadata values

Experimental condition Value
Species Mice
ElectrodeType Patch-clamp
PrepType in vitro
InternalSolution 5.0
ExternalSolution 5.0
JxnPotential Unreported
AnimalAge 90.0
RecTemp 31.0
Strain Other
internal_0_pH 7.3
internal_0_Mg 2.0
internal_0_Na 20.8
internal_0_K 133.0
internal_0_GTP 0.4
internal_0_ATP 4.0
internal_0_HEPES 10.0
internal_0_Cl 9.0
external_0_pH 7.4
external_0_Mg 2.0
external_0_Na 155.25
external_0_K 3.0
external_0_Cl 135.0
external_0_Ca 2.0
external_0_glucose 10.0

Data table listing

Data Table Article Title Authors Journal Year Table needs expert? Ephys table mentions Curated by Times validated
47234 Postnatal day 2 to 11 constitutes a 5-HT-sensitive period impacting adult mPFC function. Rebello TJ; Yu Q; Goodfellow NM; Caffrey Cagliostro MK; Teissier A; Morelli E; Demireva EY; Chemiakine A; Rosoklija GB; Dwork AJ; Lambe EK; Gingrich JA; Ansorge MS J. Neurosci. 2014 False 5 Brenna Li, Ryan Sefidpour, 1
47230 Postnatal day 2 to 11 constitutes a 5-HT-sensitive period impacting adult mPFC function. Rebello TJ; Yu Q; Goodfellow NM; Caffrey Cagliostro MK; Teissier A; Morelli E; Demireva EY; Chemiakine A; Rosoklija GB; Dwork AJ; Lambe EK; Gingrich JA; Ansorge MS J. Neurosci. 2014 False 0 None
47231 Postnatal day 2 to 11 constitutes a 5-HT-sensitive period impacting adult mPFC function. Rebello TJ; Yu Q; Goodfellow NM; Caffrey Cagliostro MK; Teissier A; Morelli E; Demireva EY; Chemiakine A; Rosoklija GB; Dwork AJ; Lambe EK; Gingrich JA; Ansorge MS J. Neurosci. 2014 False 0 None
47232 Postnatal day 2 to 11 constitutes a 5-HT-sensitive period impacting adult mPFC function. Rebello TJ; Yu Q; Goodfellow NM; Caffrey Cagliostro MK; Teissier A; Morelli E; Demireva EY; Chemiakine A; Rosoklija GB; Dwork AJ; Lambe EK; Gingrich JA; Ansorge MS J. Neurosci. 2014 False 0 None
47233 Postnatal day 2 to 11 constitutes a 5-HT-sensitive period impacting adult mPFC function. Rebello TJ; Yu Q; Goodfellow NM; Caffrey Cagliostro MK; Teissier A; Morelli E; Demireva EY; Chemiakine A; Rosoklija GB; Dwork AJ; Lambe EK; Gingrich JA; Ansorge MS J. Neurosci. 2014 False 0 None